KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-control

The utility of KRAS mutations in plasma circulating cell-free DNA (cfDNA) samples as non-invasive biomarkers for the detection of pancreatic cancer has never been evaluated in a large case-control series. We applied a KRAS amplicon-based deep sequencing strategy combined with analytical pipeline spe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Le Calvez-Kelm, Florence, Foll, Matthieu, Wozniak, Magdalena B., Delhomme, Tiffany M., Durand, Geoffroy, Chopard, Priscilia, Pertesi, Maroulio, Fabianova, Eleonora, Adamcakova, Zora, Holcatova, Ivana, Foretova, Lenka, Janout, Vladimir, Vallee, Maxime P., Rinaldi, Sabina, Brennan, Paul, McKay, James D., Byrnes, Graham B., Scelo, Ghislaine
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346680/
https://ncbi.nlm.nih.gov/pubmed/27705932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12386
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller